Giá của TME Pharma N.V. là bao nhiêu (ALTME)

Giá của TME Pharma N.V. (ALTME) là $0.07828624

Mũ thị trường của TME Pharma N.V. là gì (ALTME)

Giới hạn thị trường của TME Pharma N.V. (ALTME) là $7.37M

TME Pharma N.V. (ALTME) Giá và Vốn Hóa Thị Trường

TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.

Giá của ALTME	Tài sản B	Thị trường của B	Kết quả
$57,880.05 $7.37M	NVDA	$5.452T	+73,933,766.86%
$47,668.54 $7.37M	AAPL	$4.490T	+60,889,960.00%
$44,190.42 $7.37M	GOOG	$4.162T	+56,447,132.65%
$39,030.09 $7.37M	MSFT	$3.676T	+49,855,513.84%
$30,077.15 $7.37M	AMZN	$2.833T	+38,419,356.70%

Giá của ALTME

Tài sản B

Thị trường của B

Kết quả

$57,880.05 $7.37M